BridgeMD
Tests treatment safety and results for Hemiplegic Shoulder Pain
Official title Comparison of Effectiveness of Low Dose Laser and Transcutaneous Electrical Stimulation in Hemiplegic Shoulder
ClinicalTrials.gov ID: NCT07203222
What this study is testing
- What it's testing
- The primary aim of this study is to compare the efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) and Low Level Laser Therapy (LLLT), which are analgesic modalities that play an important role in the treatment of this frequently encountered complication. The secondary aim of the study is to evaluate its effectiveness on upper extremity function, quality of life, sleep, and fatigue.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Patients aged 18-75 years
- Patients with shoulder pain on the hemiplegic side \ Mini mental state examination ≥ 25
- History of stroke within the last 2 weeks to 6 months
- Patients with shoulder pain scoring 40-100 points on the visual analogue scale (moderate to severe) will be included.
You likely can't join if
- Patients who refuse to provide written consent or attend follow-up visits
- Being under 18 years of age
- Patients with motor aphasia
- Patients who have had a shoulder injection within the last 3 months
- Patients who have undergone upper extremity botulinum toxin application within the last 6 months \ Pregnant women or those planning to become pregnant
- Inflammatory rheumatic disease
See the full eligibility criteria
- Patients aged 18-75 years
- Patients with shoulder pain on the hemiplegic side \ Mini mental state examination ≥ 25
- History of stroke within the last 2 weeks to 6 months
- Patients with shoulder pain scoring 40-100 points on the visual analogue scale (moderate to severe) will be included.
- Patients who refuse to provide written consent or attend follow-up visits
- Being under 18 years of age
- Patients with motor aphasia
- Patients who have had a shoulder injection within the last 3 months
- Patients who have undergone upper extremity botulinum toxin application within the last 6 months \ Pregnant women or those planning to become pregnant
- Inflammatory rheumatic disease
- Patients who have undergone shoulder injury and surgery prior to stroke
- Patients with other conditions that could explain shoulder pain
- Patients with complex regional pain syndrome
- Patients with a history of epilepsy, pacemaker, or arrhythmia diagnosis
- Malignancy
- Diseases such as Alzheimer's or dementia that cause cognitive impairment -History of psychiatric disorders such as major depression or personality disorders
- Alcohol and drug addiction
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Yenimahalle, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Yenimahalle, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.